Oncocyte Corporation - Common Shares, No Par Value (OCX)

Historical Holders from Q4 2015 to Q2 2025

Symbol
OCX on Nasdaq
Type / Class
Equity / Common Shares, No Par Value
Shares outstanding
28.5M
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oncocyte Corporation - Common Shares, No Par Value (OCX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIO-RAD LABORATORIES, INC. 9.7% $608K 2.76M BIO-RAD LABORATORIES, INC 10 Feb 2025
SMITH PATRICK W 10.5% $4.22M 1.77M Patrick W. Smith 26 Dec 2024

Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$127K 0
2025 Q1 44.4K $127K -$7.72K $2.86 1
2024 Q4 47.1K $112K -$29.2K $2.38 1
2024 Q3 59.4K $169K -$3.22M $2.85 1
2024 Q2 1.15M $3.4M +$1.01M $2.95 2
2024 Q1 810K $2.37M -$46.2K $2.93 2
2023 Q4 826K $2.05M -$20.4K $2.49 2
2023 Q3 834K $2.72M -$68.4M $3.20 2
2023 Q2 91.8M $21.1M +$8.24M $0.23 45
2023 Q1 55.7M $19.7M -$1.79M $0.35 51
2022 Q4 60.7M $19.5M -$2.6M $0.32 55
2022 Q3 66.1M $48.3M -$1.94M $0.73 55
2022 Q2 68.7M $61.8M +$12.1M $0.90 64
2022 Q1 54.3M $81M -$2.23M $1.49 76
2021 Q4 55.3M $120M -$4.93M $2.17 82
2021 Q3 56.6M $202M -$4.27M $3.56 91
2021 Q2 56.6M $325M +$10.1M $5.74 88
2021 Q1 54.5M $283M +$113M $5.19 84
2020 Q4 32.8M $78.4M +$4.66M $2.39 56
2020 Q3 31.3M $43.5M -$4.54M $1.39 55
2020 Q2 32.9M $62.9M +$9.18M $1.91 57
2020 Q1 27.7M $67.7M +$4.42M $2.45 52
2019 Q4 25.9M $58.2M +$15.6M $2.25 50
2019 Q3 19M $39.9M +$6.04M $2.10 53
2019 Q2 16M $39.8M -$2.94M $2.49 48
2019 Q1 16.1M $63.7M +$30.8M $3.95 45
2018 Q4 8.32M $11.5M -$816K $1.38 14
2018 Q3 8.72M $21.8M -$155K $2.50 20
2018 Q2 8.78M $22.4M +$392K $2.55 24
2018 Q1 8.63M $18.1M +$8.21M $2.10 27
2017 Q4 4.68M $21.7M +$1.17M $4.65 32
2017 Q3 4.41M $33.3M +$3.97M $7.55 28
2017 Q2 3.9M $20.3M +$545K $5.19 30
2017 Q1 3.78M $22.5M +$4.36M $5.94 25
2016 Q4 3.12M $22M +$339K $7.05 24
2016 Q3 3.08M $15.5M +$7.6M $5.02 20
2016 Q2 1.58M $5.63M -$394K $3.56 24
2016 Q1 1.67M $7.69M +$2.64M $4.61 35
2015 Q4 1.09M $6.84M +$6.84M $6.24 4